Autres langues BioSyent Inc.

Actions

Marché Fermé - Toronto S.E. Autres places de cotation 21:59:59 26/04/2024			Varia. 5j.	Varia. 1 janv.
8,51 ^CAD	0,00 %		+0,12 %	-7,70 %

01/04	BioSyent se présentera à la conférence des investisseurs de LD Micro à New York	MT
13/03	BioSyent Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

BioSyent to Attend Planet MicroCap Showcase	23/04
BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index	22/04
BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement	15/04
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference	10/04
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year	03/04
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year	03/04
BioSyent To Present At LD Micro New York Investor Conference	01/04
BioSyent to Present at LD Micro New York Investor Conference	01/04
BioSyent Announces Grant of Restricted Share Units	27/03
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	13/03
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	13/03
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023	13/03
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023	13/03
BioSyent Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
BioSyent Inc. Seeks Acquisitions	13/03
BioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024	06/03
BioSyent Named to 2024 TSX Venture 50	21/02
BioSyent Named to 2024 TSX Venture 50	21/02
BioSyent Declares First Quarter 2024 Dividend	06/02

Aucun résultat pour cette recherche